全球伤口凝胶市场行业概况及 2031 年预测 - 市场分析和市场份额

全球伤口凝胶市场概况

伤口凝胶在伤口护理中至关重要，主要由大量的水制成，以保持湿润的愈合环境。它们促进气体交换和组织再生，这对于有效愈合至关重要。例如，由聚丙烯酰胺和琼脂组成的水凝胶可保持皮肤湿润，提供光滑、有弹性和透明的表面。先进的伤口凝胶通常包括抗菌剂、生长因子和干细胞等生物活性成分，通过预防感染和促进身体的自然修复过程来增强愈合。这种创新推动了伤口凝胶市场的增长。

数据桥市场研究市场报告提供了最新发展、贸易法规、市场份额、基于细分和区域分析的市场趋势、市场参与者的影响、新兴收入领域的机会分析、市场法规、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地理扩展和市场技术创新的详细信息。要获取有关市场的更多信息，请联系数据桥市场研究的专家分析师团队。我们的团队将帮助您做出明智的市场决策，以实现业务增长。

全球伤口凝胶市场规模

As the population ages and the incidence of chronic diseases such as diabetes rises, the number of individuals suffering from hard-to-heal wounds is expected to increase substantially. This growing patient population will require advanced wound care products to promote healing, prevent complications, and improve quality of life. Wound gels, which provide a moist healing environment while delivering active ingredients to the wound bed, are a critical component of the treatment for many acute and chronic wounds. Manufacturers are expected to scale up the production of wound gels to meet the rising demand for effective wound care. Additionally, they will need to invest more in research and development to bring innovative products to market. Distributors and healthcare providers will also need to ensure adequate supplies of wound gels to meet the needs of the expanding population of patients with chronic wounds. Databridge Market Research took a dive into comprehensively analyzing the market and unveiled that the global wound gel market is increasing at a CAGR of 6.10%. The size of the market is valued at USD 22.51 billion in 2023 and is expected to grow up to USD 36.16 billion by 2031.

Wound Gel Market Dynamics

Wound Gel Market Growth Drivers

Rising Incidence of Surgical Procedures

The rising incidence of surgical procedures significantly impacts the growth of the wound gel market. As surgical operations increase globally, the associated risks of complications, particularly surgical site infections (SSIs), have also risen. Studies show that surgical site infections (SSIs) can occur in up to 2% of surgical cases that results in longer hospital stays and higher healthcare costs, with an average additional expense of $18,626 per infection for Medicare patients. This financial burden, coupled with the heightened awareness of patient safety and recovery outcomes, drives demand for advanced wound care products, including wound gels. These gels are essential in surgical settings where the risk of SSIs is high, as they help to promote healing and prevent infections. Furthermore, with the trend towards minimally invasive surgeries, which often require specialized wound care solutions, the wound gel market is expected to expand as healthcare providers seek effective ways to manage surgical wounds and enhance patient recovery.

Growing Awareness and Education

The growing awareness and education surrounding wound care is an important factor drives the expansion of the wound gel market. As healthcare organizations and wound care associations launch educational campaigns, they effectively spread crucial information about the risks associated with improper wound management and the benefits of advanced wound care products. This increased awareness is crucial due to the growing incidence of chronic wounds, particularly among the elderly and those with conditions such as diabetes. This highlights the critical need for effective wound care solutions. Additionally, the advancement of innovative and user-friendly wound care products has made it easier for patients to manage their wounds at home that leading to increased adoption and awareness of their effectiveness. As awareness of the significance of proper wound care increases, the demand for advanced wound gels and related products is anticipated to rise. This growing awareness will drive the market forward, enabling individuals to effectively manage their wounds.

Increase in the Number of Burn Cases

The increase in burn cases significantly drives the growth of the wound gel market, particularly for advanced treatments such as hydrogel dressings. According to World Health Organization, around 180,000 burn-related deaths are estimated annually and over 500,000 individuals in the U.S. seeking treatment each year, the prevalence of burn injuries creates a substantial demand for effective wound care solutions. Wound gels are increasingly favored due to their unique properties, which provide a moist healing environment, reduce pain, and protect wounds from contamination. Their ability to incorporate therapeutic agents further enhances healing and infection prevention that makes them a preferred choice for both clinicians and patients. Ongoing advancements in burn care, such as the creation of new hydrogel formulations with enhanced moisture retention and antimicrobial properties, are essential for effectively managing the challenges associated with severe burn injuries. As healthcare providers focus on improving patient outcomes, the increasing prevalence of burn injuries is driving demand for advanced wound care products. This trend is prompting manufacturers to invest more in research and development that improves treatment efficacy and reducing complications associated with burn wounds.

Global Wound Gel Market Growth Opportunities

The wound gel market is expected for significant growth in the coming years, driven by the expansion of healthcare infrastructure in emerging economies. The demand for specialized wound care products such as wound gels, is expected to rise due to enhanced capabilities and accessibility of healthcare facilities. Improved infrastructure facilitates the distribution of these products and encourages healthcare providers to adopt advanced solutions necessary for effectively managing complex wounds. Furthermore, increased healthcare spending by governments and private entities will enable the procurement of high-quality wound care products that provides better long-term outcomes. This shift towards value-based care emphasizes the importance of investing in advanced wound care solutions, thereby creating a favorable environment for the wound gel market to grow.

Wound Gel Market Size Growth Challenges

The financial burden on the wound gel market presents significant challenges that can hinder its growth and expansion. The high development costs associated with research, clinical trials, and regulatory compliance affects the smaller firms and startups that may lack the financial resources. Additionally, the high prices of advanced wound gels render them less accessible in price-sensitive healthcare environments that leads to slower adoption rates among consumers and healthcare providers. This price sensitivity is exacerbated by competition from more affordable alternative treatments, which may lead healthcare providers to choose less expensive options that limits the market potential for wound gels. Limited financial resources hinder efforts to raise awareness and demonstrate the value of these products which makes it difficult for companies to effectively market their innovations and educate potential users about their benefits.

Wound Gel Market Size Growth Restraints   

The side effects due to wound gels, especially those containing active ingredients such as silver or antibiotics, significantly hinder the market growth of these products. Adverse reactions such as skin irritation, allergic reactions, and the development of antibiotic resistance can limit their use and acceptance among healthcare providers and patients. For instance, while silver-based wound gels are effective in preventing infections, they can also lead to argyria, a condition where silver accumulates in the body that causes a bluish-gray discoloration of the skin. Additionally, the overuse of antibiotic-infused gels can contribute to the growing problem of antibiotic resistance which makes infections harder to treat. Furthermore, the potential for adverse effects can lead to increased regulatory scrutiny and the need for extensive clinical trials that further complicates the development and approval processes for new wound gel formulations. As a result, the combination of safety concerns, regulatory challenges, and the need for ongoing education about proper use limits the wound gel market growth.

Wound Gel Market Scope and Trends

• Amorphous hydrogels, such as EHO-85, are designed to maintain optimal moisture levels in the wound bed.
• Amorphous hydrogels facilitate autolytic debridement, which helps in the removal of necrotic tissue while keeping the wound moist and warm.
• Aurix Gel is a type of wound gel which provides an effective treatment for chronic diabetic foot ulcers due to its unique formulation that promotes faster tissue repair and recovery and reduces inflammation.
• Venous leg ulcers are persistent skin wounds due to poor blood circulation from venous insufficiency that affects up to 2% of people and often recurring in 50-70% of cases within six months.
• Wound gels help venous leg ulcers to heal by maintaining a moist environment and reducing infection risk.

Wound Gel Market Regional Analysis – Market Trends

Key Insights

• The U.S. dominates the North American market due to technological advancements and the presence of major players.
• 严格的环境法规和对工人安全的关注正在推动欧洲采用自动润滑系统。
• 欧盟委员会的《净零工业法案》旨在为欧盟的工业能力设立目标，重点简化关键技术的监管框架。
• 德国引领欧洲市场，而英国则表现出快速的增长，凸显了市场动态的区域差异。
• 德国占据欧洲自动润滑系统市场的近20%。
• 中国的建筑业占其GDP的6%，是亚太地区自动润滑系统市场的重要推动力。

伤口凝胶市场的领先企业

• Smith+Nephew（英国）
• Mölnlycke Health Care AB（瑞典）
• 百特（美国）
• 3M（美国）
• Integra LifeSciences（美国）
• 康维德集团 (英国)
• Coloplast A/S（丹麦）
• 美敦力（爱尔兰）
• PAUL HARTMANN AG（德国）
• MiMedx（美国）
• DeRoyal Industries Inc.，（美国）
• Organogenesis Inc.，（美国）
• 凯雷吉斯（冰岛）
• ACell Inc.，（美国）
• Lohmann & Rauscher GmbH & Co. KG（德国）
• 美德乐公司（瑞士）
• 塔利集团（英国）
• Pensar Medical LLC（美国）
• B.Braun Melsungen AG（德国）
• 康德乐 (美国)
• Bioventus LLC.（美国）
• Zimmer Biomet（美国）
• DermaRite Industries LLC（美国）
• Medline Industries Inc.，（美国）
• Brightwake Ltd（英国）
• MilLaboratories Pvt. Ltd.（印度）
• Welcare Industries Spa.（意大利）
• Haromed BVBA（比利时）

伤口凝胶市场的最新发展

• 2023年1月，康维泰克集团推出了适用于各种伤口类型的多功能敷料ConvaFoam，增强了其在伤口管理中的适用性。
• 2022 年 9 月，MiMedx 集团推出了 AMNIOEFFECT，这是一种三层人体组织同种异体移植，旨在改善复杂伤口的愈合效果
• 2024 年 3 月，Sanara MedTech 在财报电话会议上宣布了重大进展和战略计划，最新更新如下。
• 2020 年 2 月，Integra LifeSciences 推出了新一代伤口护理产品 AmnioExcel Plus 胎盘同种异体移植膜。该产品采用更厚的三层结构（羊膜、绒毛膜和羊膜）来支持软组织修复，并利用 DryFlex 技术来保存天然生长激素、细胞因子和细胞外基质(ECM )。

DBMR 关于全球伤口凝胶市场的市场报告将为您提供宝贵的见解，这些见解有助于您做出多项重要的业务决策。根据我们的报告和研究专业知识，您可以为您的业务制定切实可行的增长战略。    

SKU-26512